CONMED (CNMD)
(Delayed Data from NYSE)
$71.00 USD
+0.40 (0.57%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $71.01 +0.01 (0.01%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for CONMED Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 24 | 29 | 21 | 27 | 26 |
Receivables | 242 | 191 | 184 | 177 | 189 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 318 | 332 | 232 | 195 | 165 |
Other Current Assets | 31 | 29 | 24 | 17 | 18 |
Total Current Assets | 616 | 581 | 460 | 417 | 397 |
Net Property & Equipment | 121 | 116 | 109 | 111 | 119 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 11 | 10 | 10 | 7 | 6 |
Intangibles | 1,456 | 1,497 | 1,089 | 1,120 | 1,151 |
Deposits & Other Assets | 96 | 94 | 99 | 97 | 102 |
Total Assets | 2,300 | 2,298 | 1,766 | 1,752 | 1,775 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 88 | 73 | 58 | 53 | 56 |
Current Portion Long-Term Debt | 1 | 70 | 12 | 18 | 14 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 70 | 55 | 60 | 50 | 54 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 152 | 99 | 66 | 68 | 65 |
Total Current Liabilities | 311 | 297 | 197 | 190 | 188 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 61 | 67 | 69 | 58 | 74 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 973 | 985 | 672 | 735 | 755 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 121 | 204 | 43 | 59 | 47 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,466 | 1,552 | 981 | 1,043 | 1,065 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 447 | 413 | 397 | 383 | 379 |
Retained Earnings | 453 | 413 | 497 | 457 | 471 |
Other Equity | -50 | -58 | -54 | -64 | -59 |
Treasury Stock | 15 | 23 | 54 | 68 | 81 |
Total Shareholder's Equity | 834 | 746 | 785 | 709 | 710 |
Total Liabilities & Shareholder's Equity | 2,300 | 2,298 | 1,766 | 1,752 | 1,775 |
Total Common Equity | 834 | 746 | 785 | 709 | 710 |
Shares Outstanding | 30.70 | 30.40 | 29.20 | 28.60 | 28.30 |
Book Value Per Share | 27.17 | 24.52 | 26.90 | 24.79 | 25.10 |
Fiscal Year End for CONMED Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 34 | 24 | 31 | 28 |
Receivables | NA | 241 | 242 | 230 | 229 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 322 | 318 | 326 | 327 |
Other Current Assets | NA | 38 | 31 | 39 | 31 |
Total Current Assets | NA | 636 | 616 | 626 | 616 |
Net Property & Equipment | NA | 118 | 121 | 120 | 117 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 11 | 0 | 0 |
Intangibles | NA | 1,448 | 1,456 | 1,473 | 1,481 |
Deposits & Other Assets | NA | 108 | 96 | 107 | 109 |
Total Assets | NA | 2,309 | 2,300 | 2,326 | 2,323 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 102 | 88 | 82 | 79 |
Current Portion Long-Term Debt | NA | 1 | 1 | 71 | 70 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 50 | 70 | 60 | 55 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 139 | 152 | 163 | 150 |
Total Current Liabilities | NA | 291 | 311 | 376 | 353 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 64 | 61 | 67 | 66 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 990 | 973 | 942 | 971 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 121 | 144 | 152 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 1,455 | 1,466 | 1,529 | 1,543 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 458 | 447 | 440 | 433 |
Retained Earnings | NA | 466 | 453 | 426 | 416 |
Other Equity | NA | -50 | -50 | -54 | -53 |
Treasury Stock | NA | 20 | 15 | 15 | 16 |
Total Shareholder's Equity | NA | 855 | 834 | 796 | 780 |
Total Liabilities & Shareholder's Equity | NA | 2,309 | 2,300 | 2,326 | 2,323 |
Total Common Equity | 0 | 855 | 834 | 796 | 780 |
Shares Outstanding | 30.80 | 30.80 | 30.70 | 30.70 | 30.70 |
Book Value Per Share | 0.00 | 27.75 | 27.17 | 25.94 | 25.41 |